JP2022524692A5 - - Google Patents
Info
- Publication number
- JP2022524692A5 JP2022524692A5 JP2021539095A JP2021539095A JP2022524692A5 JP 2022524692 A5 JP2022524692 A5 JP 2022524692A5 JP 2021539095 A JP2021539095 A JP 2021539095A JP 2021539095 A JP2021539095 A JP 2021539095A JP 2022524692 A5 JP2022524692 A5 JP 2022524692A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- item
- domain
- tcrβv
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788497P | 2019-01-04 | 2019-01-04 | |
| US62/788,497 | 2019-01-04 | ||
| US201962803893P | 2019-02-11 | 2019-02-11 | |
| US62/803,893 | 2019-02-11 | ||
| PCT/US2020/012162 WO2020142672A2 (en) | 2019-01-04 | 2020-01-03 | Anti-tcr antibody molecules and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022524692A JP2022524692A (ja) | 2022-05-10 |
| JP2022524692A5 true JP2022524692A5 (cg-RX-API-DMAC7.html) | 2023-03-06 |
| JP7700039B2 JP7700039B2 (ja) | 2025-06-30 |
Family
ID=71407087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539095A Active JP7700039B2 (ja) | 2019-01-04 | 2020-01-03 | 抗tcr抗体分子およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220064255A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3906057A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7700039B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113543807A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020204686A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3125345A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2595980B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020142672A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110352068A (zh) | 2016-12-02 | 2019-10-18 | 南加利福尼亚大学 | 合成的免疫受体及其使用方法 |
| US12247060B2 (en) | 2018-01-09 | 2025-03-11 | Marengo Therapeutics, Inc. | Calreticulin binding constructs and engineered T cells for the treatment of diseases |
| EP3765517A1 (en) | 2018-03-14 | 2021-01-20 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
| WO2020010250A2 (en) | 2018-07-03 | 2020-01-09 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| JP7579795B2 (ja) | 2019-02-21 | 2024-11-08 | マレンゴ・セラピューティクス,インコーポレーテッド | NKp30に結合する抗体分子およびその使用 |
| AU2020226893B2 (en) | 2019-02-21 | 2025-02-27 | Marengo Therapeutics, Inc. | Multifunctional molecules that bind to T cell related cancer cells and uses thereof |
| CN119954959A (zh) | 2019-03-11 | 2025-05-09 | 詹森生物科技公司 | 抗Vβ17/抗CD123双特异性抗体 |
| CN115003698A (zh) * | 2019-11-14 | 2022-09-02 | 马伦戈治疗公司 | 抗tcr抗体分子及其用途 |
| WO2021138474A2 (en) | 2020-01-03 | 2021-07-08 | Marengo Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| AU2021313058A1 (en) * | 2020-07-23 | 2023-03-30 | Dyne Therapeutics, Inc. | Muscle-targeting complexes and uses thereof |
| EP4185320A4 (en) * | 2020-07-23 | 2025-10-08 | Dyne Therapeutics Inc | MUSCLE TARGETING COMPLEXES AND THEIR USES IN THE TREATMENT OF MUSCLE ATROPHY |
| MX2023000984A (es) * | 2020-07-23 | 2023-05-03 | Dyne Therapeutics Inc | Complejos dirigidos al musculo y usos de los mismos para el tratamiento de distrofinopatias. |
| IL300505A (en) | 2020-08-10 | 2023-04-01 | Janssen Biotech Inc | Materials and methods for the production of biologically engineered virus-specific lymphocytes |
| UY39415A (es) | 2020-09-11 | 2022-03-31 | Janssen Biotech Inc | Métodos y composiciones para modular la inmunidad mediada por cadenas beta |
| WO2022056197A1 (en) | 2020-09-11 | 2022-03-17 | Janssen Biotech, Inc. | Immune targeting molecules and uses thereof |
| IL301242A (en) * | 2020-09-11 | 2023-05-01 | Janssen Biotech Inc | Multi-specific immune targeting molecules and uses thereof |
| KR20240004937A (ko) | 2021-05-05 | 2024-01-11 | 이매틱스 바이오테크놀로지스 게엠베하 | Bma031 항원 결합 폴리펩타이드 |
| CN115820697B (zh) * | 2022-09-23 | 2024-07-30 | 中国海洋大学 | 一种免疫细胞及其制备方法和应用 |
| CN120897930A (zh) * | 2022-12-27 | 2025-11-04 | 耶鲁大学 | TCR-Vβ特异性治疗性分子及其用途 |
| WO2024140981A1 (zh) * | 2022-12-30 | 2024-07-04 | 上药生物治疗(香港)有限公司 | 细胞原位分泌抗体及其用途 |
| EP4683651A2 (en) * | 2023-03-21 | 2026-01-28 | Marengo Therapeutics, Inc. | Tcr targeting molecules and uses thereof |
| WO2024197296A1 (en) | 2023-03-23 | 2024-09-26 | Bodhi Bio Llc | Compositions and methods for antigen-specific therapy |
| CN121487747A (zh) * | 2023-04-27 | 2026-02-06 | 马伦戈治疗公司 | 使用与tcr结合的分子的组合疗法 |
| US20250074966A1 (en) * | 2023-08-31 | 2025-03-06 | Adaptive Biotechnologies Corporation | Agents and methods for preventing or inhibiting adaptive immune responses associated with multiple sclerosis |
| IL326971A (en) * | 2023-09-05 | 2026-05-01 | Michele Pitaro | Single-chain variable fragment and molecules derived therefrom that bind the trvb5-1 fragment of the β chain of the human T-cell receptor |
| WO2026011097A1 (en) * | 2024-07-03 | 2026-01-08 | Yale University | Antibody drug conjugates comprising tcr-vbeta specific therapeutic molecules and uses thereof |
| WO2026026858A1 (en) * | 2024-07-30 | 2026-02-05 | Biomap (Suzhou) Intelligent Technology Limited | Dsg2 antibody and uses thereof |
| CN120064640B (zh) * | 2025-01-15 | 2026-01-23 | 中牧实业股份有限公司 | 一种猪细小病毒vp2双抗体夹心定量检测试剂盒及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5766947A (en) * | 1988-12-14 | 1998-06-16 | Astra Ab | Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor |
| JPH0787994A (ja) * | 1993-04-30 | 1995-04-04 | Sumitomo Electric Ind Ltd | T細胞抗原受容体Vβ22に対するモノクローナル抗体及びその製造方法 |
| NZ330995A (en) * | 1996-10-04 | 2000-12-22 | Univ Jefferson | Generation of T cells mediating an immune response and use for treating cancer |
| WO2007042809A2 (en) * | 2005-10-11 | 2007-04-19 | Domantis Limited | Antibody polypeptide library screening and selected antibody polypeptides |
| US20130273089A1 (en) * | 2011-11-03 | 2013-10-17 | Tolera Therapeutics, Inc. | Antibody and methods for selective inhibition of t-cell responses |
| CN122399016A (zh) * | 2014-03-15 | 2026-07-17 | 诺华股份有限公司 | 使用嵌合抗原受体治疗癌症 |
| US10647768B2 (en) * | 2014-05-29 | 2020-05-12 | Macrogenics, Inc. | Multi-chain polypeptide-containing tri-specific binding molecules |
| HRP20191800T1 (hr) * | 2015-05-13 | 2019-12-27 | Ablynx N.V. | Polipeptidi koji regrutiraju t stanice koji se temelje na tcr alfa/beta reaktivnosti |
| KR20180020202A (ko) * | 2015-06-01 | 2018-02-27 | 메디진 이뮤노테라피스 게엠바하 | T 세포 수용체 특이적 항체 |
| WO2017040930A2 (en) * | 2015-09-03 | 2017-03-09 | The Trustees Of The University Of Pennsylvania | Biomarkers predictive of cytokine release syndrome |
| CN110177803A (zh) * | 2016-11-22 | 2019-08-27 | T细胞受体治疗公司 | 用于使用融合蛋白进行tcr重新编程的组合物和方法 |
| WO2020010250A2 (en) * | 2018-07-03 | 2020-01-09 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
-
2020
- 2020-01-03 JP JP2021539095A patent/JP7700039B2/ja active Active
- 2020-01-03 GB GB2109794.4A patent/GB2595980B/en active Active
- 2020-01-03 EP EP20736073.6A patent/EP3906057A4/en active Pending
- 2020-01-03 AU AU2020204686A patent/AU2020204686A1/en not_active Abandoned
- 2020-01-03 CN CN202080018799.0A patent/CN113543807A/zh active Pending
- 2020-01-03 CA CA3125345A patent/CA3125345A1/en active Pending
- 2020-01-03 WO PCT/US2020/012162 patent/WO2020142672A2/en not_active Ceased
-
2021
- 2021-07-02 US US17/366,638 patent/US20220064255A1/en not_active Abandoned
-
2025
- 2025-06-20 AU AU2025204695A patent/AU2025204695A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10918667B2 (en) | Modified cell expressing therapeutic agent and uses thereof | |
| US20220265721A1 (en) | Treatment using chimeric receptor t cells incorporating optimized polyfunctional t cells | |
| TWI862870B (zh) | 嵌合抗原受體療法t細胞擴增動力學及其用途 | |
| JP2020532954A5 (cg-RX-API-DMAC7.html) | ||
| JP7524465B2 (ja) | 免疫細胞機能の改善 | |
| JP7690597B2 (ja) | 免疫細胞機能の改善 | |
| KR20260013488A (ko) | 면역 이펙터 세포 및 이의 용도 | |
| TW202604968A (zh) | 多肽系統 | |
| EP4577234A1 (en) | Improving immune cell function | |
| HK40011995A (en) | Treatment using chimeric receptor t cells incorporating optimized polyfunctional t cells |